1. Home
  2. KEN vs LGND Comparison

KEN vs LGND Comparison

Compare KEN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$65.90

Market Cap

3.5B

Sector

Utilities

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$315.11

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEN
LGND
Founded
2014
1987
Country
Singapore
United States
Employees
N/A
68
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
KEN
LGND
Price
$65.90
$315.11
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$256.29
AVG Volume (30 Days)
24.6K
487.4K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
4.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.25
Revenue Next Year
N/A
$19.41
P/E Ratio
$9.21
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$41.50
$122.27
52 Week High
$95.93
$326.63

Technical Indicators

Market Signals
Indicator
KEN
LGND
Relative Strength Index (RSI) 36.65 67.37
Support Level $59.90 $180.85
Resistance Level $70.74 N/A
Average True Range (ATR) 1.49 14.06
MACD 0.52 0.47
Stochastic Oscillator 10.15 81.98

Price Performance

Historical Comparison
KEN
LGND

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: